Investor opportunities
Creavo Medical Technologies Ltd is a UK-based, privately held medical technology company that has developed an innovative diagnostic platform based technology for use in elective and emergency clinical settings.
We have held three successful investment rounds since July 2015, raising more than £20 million, by demonstrating the strength of our strategy and leadership team. We’re backed by IP Group plc, a developer of intellectual property-based businesses,which has been an investor since our inception. The company has also attracted other investors, including Parkwalk Advisors Ltd and Puhua Capital Ltd, plus long-term support from the University of Leeds.
If you are interested in discussing investment opportunities, we’d like to hear from you.
Call us
+44 (0) 1926 670560
Please send your investment enquiry via the following form
Timeline of Key Achievements
April 2014
Company created as a spin out from the University of Leeds with initial £1.6m “seed funding”
February 2015
60 60 clinical study completed at Leeds
July 2015
£4.6m raised in Series A funding round
February 2016
Company received ISO 13485
August 2016
Became Creavo Medical Technologies
November 2016
Creavo's research device receives CE mark
January 2017
Start of 750 patient, multi-site effectiveness study in five major UK ED's
May 2017
£13.4m raised in Series B funding round
Oct 2017
Creavo's research device receives FDA 510(k) approval
July 2018
Start of 720 patient, multi-site effectiveness study in five major US healthcare research facilities